These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35961417)

  • 21. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
    Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
    Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.
    Lu J; Liong M; Li Z; Zink JI; Tamanoi F
    Small; 2010 Aug; 6(16):1794-805. PubMed ID: 20623530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers.
    Wang Y; Gou K; Guo X; Ke J; Li S; Li H
    Acta Biomater; 2021 Mar; 123():72-92. PubMed ID: 33454385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review.
    Zhang Y; Lin X; Chen X; Fang W; Yu K; Gu W; Wei Y; Zheng H; Piao J; Li F
    Int J Nanomedicine; 2024; 19():5859-5878. PubMed ID: 38887691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective.
    Hosseinpour S; Walsh LJ; Xu C
    J Mater Chem B; 2020 Nov; 8(43):9863-9876. PubMed ID: 33047764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesoporous silica nanoparticles in nanomedicine applications.
    Manzano M; Vallet-Regí M
    J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.
    Rosenholm JM; Sahlgren C; Lindén M
    Curr Drug Targets; 2011 Jul; 12(8):1166-86. PubMed ID: 21443474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
    Küçüktürkmen B; Rosenholm JM
    Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How Advancing are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature.
    Porrang S; Davaran S; Rahemi N; Allahyari S; Mostafavi E
    Int J Nanomedicine; 2022; 17():1803-1827. PubMed ID: 35498391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional mesoporous silica nanoparticles for biomedical applications.
    Xu B; Li S; Shi R; Liu H
    Signal Transduct Target Ther; 2023 Nov; 8(1):435. PubMed ID: 37996406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous silica nanoparticles for tissue-engineering applications.
    Chen L; Zhou X; He C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1573. PubMed ID: 31294533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications.
    Živojević K; Mladenović M; Djisalov M; Mundzic M; Ruiz-Hernandez E; Gadjanski I; Knežević NŽ
    J Control Release; 2021 Sep; 337():193-211. PubMed ID: 34293320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platforms.
    Zhao H; Li Y; Chen J; Zhang J; Yang Q; Cui J; Shi A; Wu J
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113758. PubMed ID: 38241892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.